Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The study for CT-388 is a Phase 1 clinical trial that aims to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a drug intended for the treatment of obesity and Type 2 Diabetes Mellitus (T2DM)
The protein concentration was quantified using the bicinchoninic acid assay (Thermo Fisher Scientific, Waltham, USA), as previously described [26]
Do any of these apply to you
How quickly might I notice mood or anxiety changes on semaglutide
US$ 22.33
US$ 27.24
US$ 20.81
